Table 2.

Proportion of PLHIV at risk of ATI and PLHIV who flowed in and out of each province during the COVID‐19 outbreak in 31 provinces and municipalities in mainland China

Province	Region in China	No. PLHIV recruited	% PLHIV at risk of ATI	% PLHIV at threatened but resolved risk of ATI	% PLHIV at risk of imminent ATI	% PLHIV who experienced ATI	No. PLHIV flowed out to another province	No. PLHIV flowed in from another province
Jiangsu	Eastern	425	33.41	15.29	16.94	1.18	120	57
Shanghai		154	35.72	20.13	12.99	2.60	82	21
Shandong		256	30.85	15.23	14.06	1.56	38	72
Jiangxi		93	34.41	11.83	19.35	3.23	23	51
Fujian		99	26.26	10.10	14.14	2.02	15	40
Anhui		132	36.36	16.67	17.42	2.27	25	93
Zhejiang		371	51.48	23.18	23.72	4.58	143	29
Hubei	South‐Central	223	58.74	18.83	37.67	2.24	36	141
Hunan		171	28.66	11.70	12.87	4.09	31	78
Henan		238	44.54	17.23	22.27	5.04	25	106
Hainan		51	21.56	9.80	11.76	0.00	14	22
Guangdong		507	38.46	12.23	23.27	2.96	239	34
Guangxi		98	29.59	9.18	18.37	2.04	14	45
Chongqing	Southwest	208	30.77	15.87	12.50	2.40	39	26
Sichuan		314	27.71	12.42	13.06	2.23	57	84
Yunnan		94	27.66	8.51	17.02	2.13	26	18
Guizhou		167	25.15	7.19	14.37	3.59	15	33
Xinjiang	Northwest	139	51.79	21.58	22.30	7.91	20	25
Shaanxi		185	38.37	14.05	21.08	3.24	36	34
Gansu		51	37.25	11.76	19.61	5.88	4	29
Heilongjiang	Northeast	104	24.03	8.65	12.50	2.88	15	48
Jilin		77	20.78	9.09	10.39	1.30	18	28
Liaoning		187	19.78	8.02	11.23	0.53	31	32
Inner Mongolia		79	26.58	11.39	15.19	0.00	3	28
Beijing	North	310	33.23	16.45	15.81	0.97	225	12
Tianjin		85	27.06	8.24	15.29	3.53	23	17
Hebei		117	29.91	11.11	16.24	2.56	18	83
Shanxi		67	22.39	8.96	13.43	0.00	4	49

Provinces that had less than 30 participants were not included in this analysis, including Tibet (3), Qinghai (9) and Ningxia (19). Participants resided in foreign areas (49) were not shown. ATI, antiretroviral therapy interruption; PLHIV, people living with HIV.